Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-15-009506
Filing Date
2015-12-14
Accepted
2015-12-14 15:14:20
Documents
4
Period of Report
2015-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp61846_6k.htm 6-K 14796
2 EXHIBIT 99.1 dp61846_ex9901.htm EX-99.1 20799
3 EXHIBIT 99.2 dp61846_ex9902.htm EX-99.2 19960
4 EXHIBIT 99.3 dp61846_ex9903.htm EX-99.3 23768
  Complete submission text file 0000950103-15-009506.txt   80291
Mailing Address JOUKAHAISENKATU 6 TURKU H9 FI-20520
Business Address JOUKAHAISENKATU 6 TURKU H9 FI-20520 358-2-274-8900
Biotie Therapies Corp. (Filer) CIK: 0001579695 (see all company filings)

EIN.: 000000000 | State of Incorp.: H9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37423 | Film No.: 151285826
SIC: 2834 Pharmaceutical Preparations